摘要
目的观察通心络联合倍他司汀治疗椎—基底动脉供血不足(VBI)性眩晕的临床疗效。方法将60例VBI性眩晕患者随机分为2组。治疗组30例给予通心络胶囊4粒口服,每天3次;倍他司汀8mg口服,每天3次。对照组30例仅口服倍他司汀8mg,每天3次。治疗后观察2组临床疗效。结果治疗组总有效率为93.3%高于对照组的73.3%,差异有统计学意义(P<0.05)。2组治疗中未出现任何不良反应。结论通心络联合倍他司汀治疗VBI性眩晕疗效显著,安全性好,值得临床推广应用。
Objective To observe the clinical effect of tongxinluo combined with betahistine in vertebrobasilar artery ischemic （VBI） vertigo. Methods 60 cases patients with VBI vertigo were randomly divided into treatment group and control group, each of 30 cases. Treatment group were treated with tongxinluo 4 capsules, 3 times a day; Betahistine 8rag, 3 times a day. Control group were given betahistine 8mg,3 times a day. After treatment,observed the effect of two groups. Results The total effectiveness rate of treatment group（93.3% ） was higher than that of control group（73.3% ） ,the difference was statistically significant （ P 〈 0.05 ）. Conclusion Tongxinluo combined with betahistine in VBI vertigo has a nice effect, salty.
出处
《临床合理用药杂志》
2011年第21期21-22,共2页
Chinese Journal of Clinical Rational Drug Use
